result
Outcomes research and medical innovation
Leading the Green Health Care Movement
Although Houston Methodist’s Office of Sustainability is relatively new, the faculty and staff have initiated several research and operations-focused projects to conserve energy and resources.
Read now
Popular Features
Outcomes research
Addressing Global Disparities in Gynecological Cancer
Leaders call for a global movement to prioritize women’s health.
Read now
From Paralysis to Recovery
Combining spinal electrical neuromodulation and hand grip training can potentially restore hand motor function after upper limb paralysis due to cervical spinal cord injury or stroke.
Read now
precision medicine
Focus
Innovative Education
2024 Summer Internships at Houston Methodist Were a Hit
Houston Methodist welcomes undergraduates and high school students for summer research internships.
Read now
Clinical Research
CPRIT Funds Cancer Research
The Cancer Prevention and Research Institute of Texas (CPRIT) has awarded $3.4 million in funding to two Houston Methodist cancer researchers for projects to improve cancer prevention in underserved communities and advance the development of more effective multiple myeloma treatments.
Read now
Outcomes Research
From Clinic to Community
The J.C. Walter Jr. Transplant Center Minority Outreach Program increased liver transplants and referrals among Hispanics in a two-year study period. However, lack of awareness and education regarding liver transplant as an option for patients and financial roadblocks prevented many patients from receiving a liver transplant.
Read now
Restorative Medicine
Groundbreaking ALS Study Offers New Insight
Houston Methodist researchers have identified a key player and mechanism involved in the development of ALS, a promising discovery that could open the door for future therapeutic interventions.
Read now
Precision Medicine
Exploring New Horizons in Viral Myocarditis: The TRIM29-PERK Pathway
The SARS-CoV-2 virus, which causes COVID-19, can trigger viral myocarditis. Pharmacological targeting of the TRIM29-PERK axis was found to have protective effects against cardiac disease— making the PERK inhibitor a promising treatment option.
Read now
Share this story